Pemazyre

pemigatinib · Incyte Corporation

Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for Pemazyre, covering 2020-04-17 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: PH 2 Pemigatinib in SDH-deficient GIST [Phase 2]